ÂÜÀòÂÒÂ×

Catherine graduated from King’s College, Cambridge in 2000 and went on to study the biochemistry of platelet-collagen interactions, earning her PhD from Corpus Christi College, University of Cambridge. In 2003, she joined Abcam, then a small disruptive antibody supplier. Under her leadership, the in-house laboratory responsible for antibody design, manufacture and characterization grew from 4 to 40 staff. She assisted with a successful IPO on AIM in 2005 and was a member of the senior management team. She returned to academic research in 2015 as a Daphne Jackson fellow at the Wellcome Sanger Institute where she studied the role of surface proteins in parasite infection. She co-founded Qkine in 2016 to address challenges in the growth factor and complex protein supply chain and support innovations in stem cell science and regenerative medicine, areas she believes underpin future advances in human health and wellbeing.